Your gateway to insightful market trends, prudent personal finance advice, and the pulse of global economy.

USA Finance Digest is your one-stop destination for the latest financial news and insights

Your gateway to insightful market trends, prudent personal finance advice, and the pulse of global economy.

Key Points
Oracle had a weaker-than-expected quarter, but the top-line miss is slim, and margins are impressive.
A shortfall in capacity is a leading cause for weakness; capacity is ramping now and over the next several quarters, so price weakness is a likely buy-the-dip opportunity. 
Demand for capacity equals demand for accelerators, a demand that NVIDIA can’t fill by itself: there is a void for Advanced Micro Devices to fill. 
5 stocks we like better than Oracle
Oracle NYSE: ORCL had a weaker-than-expected FQ2 relative to analysts’ expectations, but the outlook is as robust as ever. The biggest takeaway from the report is that weakness was caused by insufficient capacity, and capacity is ramping. The news for investors is that Oracle will continue to grow, cloud and AI will continue to overtake its legacy business, and the market for AI accelerators is ramping up. 
“There’s this gold rush towards building the world’s greatest large language model. And we are doing our best to give our customers what we can this quarter, and then dramatically increase our ability to give them more and more capacity each succeeding quarter,” said chairman and co-founder Larry Ellison during the conference call. 
Among the causes of insufficient capacity is a shortfall of NVDA NASDAQ: NVDA and other capable accelerators. NVIDIA is ramping up production as quickly as it can, but there is a void to be filled. Advance Micro Devices NASDAQ: AMD is the leading player to fill the void, which launched its AI-specific accelerators, and Oracle is a known partner. 
This means that NVIDIA can be expected to have another mind-blowing year in 2024, and Advanced Micro Devices will also have an NVIDIA-like year. AMD’s new line of MI-300 accelerators provides a choice for the leading cloud operators and enhances performance for clients in many use cases, so it will likely significantly exceed CEO Lisa Su’s $2 billion revenue target. 
Oracle has a solid quarter; shares implode
Oracle had a solid quarter with revenue of $12.94 billion, growing 5.4% YOY. This is weaker than expected but by a slim 80 basis points and offset by strength in critical segments, a healthy outlook for growth and a widening margin. The Cloud segments led with growth of 25%, offset by weaker sales in legacy businesses. Within the cloud segment, services grew by 15%, while infrastructure grew by more than 50%. Margin news is impressive for this tech stock. Strong gross and operating margins offset the company’s slim top-line weakness; the operating margin is up 200 bps YOY on scale and leverage, leaving adjusted earnings above the consensus. Adjusted earnings came in at $1.34 or a penny hot, giving a taste of what’s to come over the next few quarters as Oracle builds its data center empire. The company has plans to build dozens more data centers over the coming years, including private clouds for governments and large enterprises. 
Oracle’s guidance is a factor weighing on the share price. The guidance is favorable, expecting growth near 7% and wider margins, but aligns with’s analyst consensus estimate, providing no catalyst to rally. However, the guidance remains solid; the company is on track to grow consistently over the next few years, so the price pullback is a likely buy-the-dip opportunity for investors. 
Analysts trim targets: it’s wait-and-see time for Oracle
Analysts remain bullish on Oracle but began trimming price targets following the Q2 release. The first two showing up on Marketbeat’s radar are from UBS Group and BMO Capital Markets, which lowered their targets to $125 and $126, respectively. The bad news is that more downward revisions may come; the good news is that these targets are above consensus, and the consensus figure has been relatively steady for the last few months, implying about a 20% upside with the post-release plunge in share prices. 
Shares of Oracle fell about 10% following the release and are trading near the bottom of a major consolidation range. This range has been in play since the AI boom drove the stock to new highs early in 2023. Because the outlook is still robust, Oracle shares will unlikely fall below the range; instead, they will likely continue to consolidate within it as analysts and investors wait and see what comes next. Assuming the company continues its plans, the following quarters should produce significant growth, widening margin and ample cash flow for repurchases and dividends. 
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Oracle wasn’t on the list.While Oracle currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here Click the link below and we’ll send you MarketBeat’s guide to pot stock investing and which pot companies show the most promise. Get This Free Report

Share this article
Shareable URL
Prev Post
Next Post
Leave a Reply

Your email address will not be published. Required fields are marked *

Read next
Key Points is supported by AI and deepening penetration of services, compounded by higher…
Key Points REGN excels with strong sector outperformance and analyst favoritism owing to its diverse product…
Key Points Unity Software’s Q1 2024 report highlights its focus on optimizing its portfolio, integrating…
Key Points Abbott Laboratories had a steady quarter, with growth accelerating and better-than-expected margins.…